Skip to main content

Table 3 Percent agreement between academic readers and Veridex consensus (VC) overall and according to dataset, disease stage, circulating tumor cell (CTC) count and administration of systemic therapy before blood sample collection

From: International study on inter-reader variability for circulating tumor cells in breast cancer

 

Agreement, %

 
 

Median

Range

P-value

All

92

69 to 97

 

Dataset

   

  Institute Jules Bordet

81

61 to 97

<0.001

  Institute Curie

97

73 to 99

 

  University of Hamburg

94

69 to 98

 

Stage

   

  M0

91

70 to 96

<0.001

  M1

98

64 to 100

 

CTC count

   

  <5 CTCs

88

66 to 95

<0.001

  ≥5 CTCs

97

74 to 100

 

Systemic therapy before blood sample collection

   

  No

92

74 to 96

<0.001

  Yes

89

55 to 97

 
  1. CTC, circulating tumor cell; M0, Non-metastatic, M1, metastatic.